Literature DB >> 7588944

Detection of cervical metastases of thyroid medullary carcinoma by MoAb anti-CEA scintigraphy and immunohistochemistry.

S Parkkila1, A Ahonen, P Torniainen, J Heikkilä, P Salmela.   

Abstract

Four patients with medullary thyroid carcinoma (MTC) were examined using anti-carcinoembryonic antigen (CEA) scintigraphy. Two patients had positive and two normal scintigraphic findings, although all the patients had elevated blood test markers (calcitonin or CEA). One patient with clinical suspicion of MTC metastases had only a faintly positive anti-CEA image, although single-photon emission tomographic scanning was used to increase the sensitivity and resolution of the method. Therefore, digital image processing of the planar images was performed to obtain more detailed information. The analysis revealed distinct accumulation of the activity at the right side of the neck at 20 h post administration. The specificity of the antibody binding in the malignant cells was confirmed after surgery by immunohistochemical staining of the tumour specimens for CEA. Both conventional and confocal laser scanning microscopy revealed distinct positive staining, indicating that the results obtained from the anti-CEA scanning showed specific binding of the labelled antibody in the neoplastic tissue.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7588944     DOI: 10.1007/BF00808419

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  10 in total

1.  Medullary carcinoma of the thyroid: management of persistent hypercalcitonaemia utilizing [99mTc] (v) dimercaptosuccinic acid scintigraphy.

Authors:  R Udelsman; O A Mojiminiyi; N D Soper; I D Buley; B J Shepstone; N E Dudley
Journal:  Br J Surg       Date:  1989-12       Impact factor: 6.939

2.  Radioimmunoscintigraphy using iodine-131-anti-CEA monoclonal antibodies and thallium-201 scintigraphy in medullary thyroid carcinoma: a case report.

Authors:  D E Zanin; A van Dongen; C A Hoefnagel; P F Bruning
Journal:  J Nucl Med       Date:  1990-11       Impact factor: 10.057

Review 3.  Imaging and therapy of cancer with radiolabeled monoclonal antibodies.

Authors:  D M Goldenberg
Journal:  Prog Clin Biol Res       Date:  1989

4.  Imaging of medullary carcinoma of the thyroid using 111In-labelled anti-CEA monoclonal antibody fragments.

Authors:  K J O'Byrne; D Hamilton; I Robinson; E Sweeney; P J Freyne; M J Cullen
Journal:  Nucl Med Commun       Date:  1992-03       Impact factor: 1.690

5.  Immunohistological studies of nonthyroidal calcitonin-producing tumors.

Authors:  L J Deftos
Journal:  J Clin Endocrinol Metab       Date:  1980-06       Impact factor: 5.958

6.  New tracers for the imaging of the medullary thyroid carcinoma.

Authors:  U P Guerra; C Pizzocaro; A Terzi; R Giubbini; G Maira; R Pagliaini; M Bestagno
Journal:  Nucl Med Commun       Date:  1989-04       Impact factor: 1.690

7.  Iodine-131-labeled MAb F(ab')2 fragments are more efficient and less toxic than intact anti-CEA antibodies in radioimmunotherapy of large human colon carcinoma grafted in nude mice.

Authors:  F Buchegger; A Pèlegrin; B Delaloye; A Bischof-Delaloye; J P Mach
Journal:  J Nucl Med       Date:  1990-06       Impact factor: 10.057

8.  Intraoperative localization of recurrent medullary carcinoma of the thyroid using indium-111 pentetreotide and a nuclear surgical probe.

Authors:  W A Waddington; A G Kettle; R M Heddle; A J Coakley
Journal:  Eur J Nucl Med       Date:  1994-04

9.  Imaging of metastatic medullary carcinoma of the thyroid with 131I-meta-iodobenzyl guanidine.

Authors:  G J Poston; A M Thomas; D W Macdonald; D Karvounaris; B L Henderson; P George; J A Lynn; J P Lavender
Journal:  Nucl Med Commun       Date:  1986-04       Impact factor: 1.690

10.  Localization of recurrent medullary thyroid carcinoma with technetium-99m-methoxyisobutylnitrile scintigraphy: a case report.

Authors:  C M O'Driscoll; F Baker; M J Casey; G J Duffy
Journal:  J Nucl Med       Date:  1991-12       Impact factor: 10.057

  10 in total
  1 in total

Review 1.  Medullary thyroid cancer: medical management and follow-up.

Authors:  Amber Traugott; Jeffrey F Moley
Journal:  Curr Treat Options Oncol       Date:  2005-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.